Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
References
1. Abe R, et al., Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation. J Immuno. 1995;154:985-97. (Immunogen, FC, IP, Costim). 2 .Dodson LF, et al. Targeted knock-in mice expressing mutations of CD28 reveal an essential pathway for costimulation. Mol Cell Biol. 2009;29:3710-21. 3. Kanzaki M, et al. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes. Endocrinology. 2012;153:612-20. (Costim). 4.Tomimori Y, et al., Repeated topical challenge with chemical antigen elicits sustained dermatitis in NC/Nga mice in specific- pathogen-free condition. J Invest Dermatol. 2005;124:119-24. (Costim). 5. Zhang T, et al. Selective CD28 blockade attenuates acute and chronic rejection of murine cardiac allografts in a CTLA-4-dependent manner. Am J Transplant. 2011;11:1599-1609. (Stim). 6.Jacobsen J, et al., Naive idiotope-specific B and T cells collaborate efficiently in the absence of dendritic cells. J Immunol. 2014;192:4174-83. (FC).USBio References
No references available